Table of Contents
Epilepsy Research and Treatment
Volume 2015, Article ID 591279, 10 pages
http://dx.doi.org/10.1155/2015/591279
Research Article

Delays and Factors Related to Cessation of Generalized Convulsive Status Epilepticus

1Clinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland
2Department of Surgery, Helsinki University Central Hospital, 00029 Helsinki, Finland
3Division of Clinical Neurosciences/General Neurology, Department of Neurology, Turku University Hospital, University of Turku, 20521 Turku, Finland

Received 31 May 2015; Accepted 13 July 2015

Academic Editor: József Janszky

Copyright © 2015 Leena Kämppi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Rosenow, H. M. Hamer, and S. Knake, “The epidemiology of convulsive and nonconvulsive status epilepticus,” Epilepsia, vol. 48, no. 8, pp. 82–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. M. DeGiorgio, U. Tomiyasu, P. S. Gott, and D. M. Treiman, “Hippocampal pyramidal cell loss in human status epilepticus,” Epilepsia, vol. 33, no. 1, pp. 23–27, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. N. B. Fountain, “Status epilepticus: risk factors and complications,” Epilepsia, vol. 41, supplement 2, pp. S23–S30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Naylor, H. Liu, and C. G. Wasterlain, “Trafficking of GABAA receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus,” The Journal of Neuroscience, vol. 25, no. 34, pp. 7724–7733, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Claassen, J. K. Lokin, B.-F. M. Fitzsimmons, F. A. Mendelsohn, and S. A. Mayer, “Predictors of functional disability and mortality after status epilepticus,” Neurology, vol. 58, no. 1, pp. 139–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Agan, N. Afsar, I. Midi, O. Us, S. Aktan, and C. Aykut-Bingol, “Predictors of refractoriness in a Turkish status epilepticus data bank,” Epilepsy and Behavior, vol. 14, no. 4, pp. 651–654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Sutter, P. W. Kaplan, and S. Rüegg, “Outcome predictors for status epilepticus—what really counts,” Nature Reviews Neurology, vol. 9, no. 9, pp. 525–534, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Sutter, S. Tschudin-Sutter, L. Grize et al., “Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study,” Epilepsia, vol. 53, no. 9, pp. 1489–1497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Legriel, B. Mourvillier, N. Bele et al., “Outcomes in 140 critically ill patients with status epilepticus,” Intensive Care Medicine, vol. 34, no. 3, pp. 476–480, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. R. F. Chin, B. G. Neville, C. Peckham, A. Wade, H. Bedford, and R. C. Scott, “Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study,” The Lancet Neurology, vol. 7, no. 8, pp. 696–703, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Legriel, E. Azoulay, M. Resche-Rigon et al., “Functional outcome after convulsive status epilepticus,” Critical Care Medicine, vol. 38, no. 12, pp. 2295–2303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Kämppi, H. Mustonen, and S. Soinila, “Analysis of the delay components in the treatment of status epilepticus,” Neurocritical Care, vol. 19, no. 1, pp. 10–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Aminoff and R. P. Simon, “Status epilepticus. Causes, clinical features and consequences in 98 patients,” The American Journal of Medicine, vol. 69, no. 5, pp. 657–666, 1980. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Sagduyu, S. Tarlaci, and H. Sirin, “Generalized tonic-clonic status epilepticus: causes, treatment, complications and predictors of case fatality,” Journal of Neurology, vol. 245, no. 10, pp. 640–646, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Hillman, K. Lehtimäki, J. Peltola, and S. Liimatainen, “Clinical significance of treatment delay in status epilepticus,” International Journal of Emergency Medicine, vol. 6, no. 1, article 6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. F. B. Scholtes, W. O. Renier, and H. Meinardi, “Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients,” Epilepsia, vol. 35, no. 5, pp. 1104–1112, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Silbergleit, V. Durkalski, D. Lowenstein et al., “Intramuscular versus intravenous therapy for prehospital status epilepticus,” The New England Journal of Medicine, vol. 366, no. 7, pp. 591–600, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. E. H. Kossoff, “A shot in the arm for prehospital status epilepticus: the rampart study,” Epilepsy Currents, vol. 12, no. 3, pp. 103–104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. B. Krishnamurthy and F. W. Drislane, “Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus,” Epilepsia, vol. 37, no. 9, pp. 863–867, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. A. O. Rossetti, S. Hurwitz, G. Logroscino, and E. B. Bromfield, “Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 77, no. 5, pp. 611–615, 2006. View at Google Scholar
  21. A. O. Rossetti, G. Logroscino, T. A. Milligan, C. Michaelides, C. Ruffieux, and E. B. Bromfield, “Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy,” Journal of Neurology, vol. 255, no. 10, pp. 1561–1566, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Rantsch, U. Walter, M. Wittstock, R. Benecke, and J. Rösche, “Treatment and course of different subtypes of status epilepticus,” Epilepsy Research, vol. 107, no. 1-2, pp. 156–162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. O. Rossetti and D. H. Lowenstein, “Management of refractory status epilepticus in adults: still more questions than answers,” The Lancet Neurology, vol. 10, no. 10, pp. 922–930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Kämppi, H. Mustonen, and S. Soinila, “Factors related to delays in pre-hospital management of status epilepticus,” Neurocritical Care, vol. 22, pp. 93–104, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Meierkord, P. Boon, B. Engelsen et al., “EFNS guideline on the management of status epilepticus in adults,” European Journal of Neurology, vol. 17, no. 3, pp. 348–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. M. Brophy, R. Bell, J. Claassen et al., “Guidelines for the evaluation and management of status epilepticus,” Neurocritical Care, vol. 17, no. 1, pp. 3–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Muayqil, B. H. Rowe, and S. N. Ahmed, “Treatment adherence and outcomes in the management of convulsive status epilepticus in the emergency room,” Epileptic Disorders, vol. 9, no. 1, pp. 43–50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Vignatelli, R. Rinaldi, E. Baldin et al., “Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts,” Journal of Neurology, vol. 255, no. 2, pp. 197–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Aranda, G. Foucart, J. L. Ducassé, S. Grolleau, A. McGonigal, and L. Valton, “Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice,” Epilepsia, vol. 51, no. 10, pp. 2159–2167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. O. Rossetti, V. Alvarez, J.-M. Januel, and B. Burnand, “Treatment deviating from guidelines does not influence status epilepticus prognosis,” Journal of Neurology, vol. 260, no. 2, pp. 421–428, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. R. J. DeLorenzo, E. J. Waterhouse, A. R. Towne et al., “Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus,” Epilepsia, vol. 39, no. 8, pp. 833–840, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. A. O. Rossetti, G. Logroscino, and E. B. Bromfield, “Refractory status epilepticus: effect of treatment aggressiveness on prognosis,” Archives of Neurology, vol. 62, no. 11, pp. 1698–1702, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. F. W. Drislane, A. S. Blum, M. R. Lopez, S. Gautam, and D. L. Schomer, “Duration on refractory status epilepticus and outcome: loss of prognostic utility after several hours,” Epilepsia, vol. 50, pp. 1566–1571, 2009. View at Google Scholar
  34. S. A. Mayer, J. Claassen, J. Lokin, F. Mendelsohn, L. J. Dennis, and B.-F. Fitzsimmons, “Refractory status epilepticus: frequency, risk factors, and impact on outcome,” Archives of Neurology, vol. 59, no. 2, pp. 205–210, 2002. View at Google Scholar · View at Scopus
  35. B. Ozdilek, I. Midi, K. Agan, and C. A. Bingol, “Episodes of status epilepticus in young adults: etiologic factors, subtypes, and outcomes,” Epilepsy & Behavior, vol. 27, no. 2, pp. 351–354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Neligan and S. D. Shorvon, “Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review,” Epilepsy Research, vol. 93, no. 1, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Jaitly, J. A. Sgro, A. R. Towne, D. Ko, and R. J. DeLorenzo, “Prognostic value of EEG monitoring after status epilepticus: a prospective adult study,” Journal of Clinical Neurophysiology, vol. 14, no. 4, pp. 326–334, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. S. E. Hocker, J. W. Britton, J. N. Mandrekar, E. F. M. Wijdicks, and A. A. Rabinstein, “Predictors of outcome in refractory status epilepticus,” JAMA Neurology, vol. 70, no. 1, pp. 72–77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. G. K. Bergey, “Refractory status epilepticus: is EEG burst suppression an appropriate treatment target during drug-induced coma? What is the Holy Grail?” Epilepsy Currents, vol. 6, no. 4, pp. 119–120, 2006. View at Publisher · View at Google Scholar
  40. J. Claassen, L. J. Hirsch, R. G. Emerson, and S. A. Mayer, “Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review,” Epilepsia, vol. 43, no. 2, pp. 146–153, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. K. B. Krishnamurthy and F. W. Drislane, “Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus,” Epilepsia, vol. 40, no. 6, pp. 759–762, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Parviainen, A. Uusaro, R. Kälviäinen, E. Kaukanen, E. Mervaala, and E. Ruokonen, “High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit,” Neurology, vol. 59, no. 8, pp. 1249–1251, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Parviainen, R. Kälviäinen, and E. Ruokonen, “Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons,” Neurological Research, vol. 29, no. 7, pp. 667–671, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. B. K. Alldredge, D. Pharm, D. B. Wall, and D. M. Ferriero, “Effect of prehospital treatment on the outcome of status epilepticus in children,” Pediatric Neurology, vol. 12, no. 3, pp. 213–216, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. A. R. Towne, J. M. Pellock, D. Ko, and R. J. DeLorenzo, “Determinants of mortality in status epilepticus,” Epilepsia, vol. 35, no. 1, pp. 27–34, 1994. View at Publisher · View at Google Scholar · View at Scopus
  46. D. C. Hesdorffer, G. Logroscino, G. Cascino, J. F. Annegers, and W. A. Hauser, “Incidence of status epilepticus in Rochester, Minnesota, 1965–1984,” Neurology, vol. 50, no. 3, pp. 735–741, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. D. H. Lowenstein, “Status epilepticus: an overview of the clinical problem,” Epilepsia, vol. 40, no. 1, pp. S3–S8, 1999. View at Google Scholar · View at Scopus
  48. Y. W. Wu, D. W. Shek, P. A. Garcia, S. Zhao, and S. C. Johnston, “Incidence and mortality of generalized convulsive status epilepticus in California,” Neurology, vol. 58, no. 7, pp. 1070–1076, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Legriel, E. Azoulay, M. Resche-Rigon et al., “Functional outcome after convulsive status epilepticus,” Critical Care Medicine, vol. 38, no. 12, pp. 2295–2303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. A. O. Rossetti, G. Logroscino, and E. B. Bromfield, “A clinical score for prognosis of status epilepticus in adults,” Neurology, vol. 66, no. 11, pp. 1736–1738, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Sutter, P. W. Kaplan, and S. Rüegg, “Independent external validation of the status epilepticus severity score,” Critical Care Medicine, vol. 41, no. 12, pp. e475–e479, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Kalita, P. P. Nair, and U. K. Misra, “A clinical, radiological and outcome study of status epilepticus from India,” Journal of Neurology, vol. 257, no. 2, pp. 224–229, 2010. View at Publisher · View at Google Scholar · View at Scopus